Sentinel lymph node biopsy: Vision, multicentre trials, professional and technological synergy

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 10, 2006, Pages 1238-1241

  Lucignani, Giovanni ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; LYMPHOSCINTIGRAPHY; MELANOMA; MOUTH CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEGMENTAL MASTECTOMY; SENTINEL LYMPH NODE BIOPSY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BIOTECHNOLOGY; FORECASTING; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MULTICENTER STUDIES; MULTICENTER STUDIES AS TOPIC; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; SENTINEL LYMPH NODE BIOPSY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33749237717     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0231-2     Document Type: Review

References (11)

1. Gould EA, Winship T, Philbin PH, Kerr HH. Observations on a "sentinel node" in cancer of the parotid. Cancer 1960;13:77-8.
2. Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente C, De Lena M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981;305:6-11.
3. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes. Lancet 1997;349:1864-7.
4. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53.
5. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006;98:599-609. Erratum in: J Natl Cancer Inst. 2006;98:876.
6. Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 2006;95:279-93.
7. Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, et al. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol 2006;24:2849-57.
8. Leong SP, Accortt NA, Essner R, Ross M, Gershenwald JE, Pockaj B, et al. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaryngol Head Neck Surg 2006;132:370-3.
9. Lerman H, Metser U, Lievshitz G, Sperber F, Shneebaum S, Even-Sapir E. Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT. Eur J Nucl Med Mol Imaging 2006;33:329-37.
10. Sherif A, Garske U, de la Torre M, Thorn M. Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol 2006;50:83-91.
11. Keski-Santti H, Matzke S, Kauppinen T, Tornwall J, Atula T. Sentinel lymph node mapping using SPECT-CT fusion imaging in patients with oral cavity squamous cell carcinoma. Eur Arch Otorhinolaryngol 1996;Jul 8 [Epub ahead of print].